Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic revi...
Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Vedolizumab use in pediatrics is still off-label and the data are limited. We conducted a systematic review evaluating the efficacy and safety of vedolizumab in children and adolescents with inflammatory bowel disease (IBD).
PubMed, EMBASE and Cochrane databases were systematically searched for studies of vedolizumab in children and adolescents...
Alternative Titles
Full title
Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_39ef893eea7c45f68715a766437b4c8c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_39ef893eea7c45f68715a766437b4c8c
Other Identifiers
ISSN
1471-2431
E-ISSN
1471-2431
DOI
10.1186/s12887-022-03229-x
